Search
for
Sort by
Research 421–450 of 1000+
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- Efficacy and safety of combined microneedling therapy for androgenic alopecia: A systematic review and meta‐analysis of randomized clinical trials
- The safety and efficacy of finasteride for transgender men with androgenetic alopecia: a case series
- Chemotherapy for children with medulloblastoma
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Large-Scale, Multicenter, Prospective Registry Study of Ripretinib in Advanced GIST: A Real-World Study from China
- Ritlecitinib in severe alopecia areata: a profile of its use
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Home-based devices in dermatology: a systematic review of safety and efficacy
- Efficacy and safety of a new formulation kit (shampoo + lotion) containing anti‐inflammatory and antioxidant agents to treat hair loss
- Oral Diseases During Systemic Psoriatic Drugs: A Review of the Literature and Case Series
- Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelin
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Pilot Clinical Evaluation of a Hyaluronic Acid– and Hydrogen Peroxide–Based Gel in the Management of Folliculitis: An Open-Label, Post-Marketing Study
- Real‐world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients
- Cells to Surgery Quiz: April 2020
- Dacomitinib-Induced Paronychia Associated With PRIDE Syndrome in a Patient With Non-Small Cell Lung Cancer
- Human Placenta Extract (HPH) Suppresses Inflammatory Responses in TNF-α/IFN-γ-Stimulated HaCaT Cells and a DNCB Atopic Dermatitis (AD)-Like Mouse Model
- Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis
- Effect of a nutritional supplement on hair loss in women
- Exploring novel management options for alopecia areata
- Long‐Term Use of Tralokinumab in Patients With Atopic Dermatitis: A Real‐World Multicentric Case Series
- Combination Therapy With CGF and Microneedling‐Assisted Compound Betamethasone for Resistant Alopecia Areata: APilot Study
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial